SalA mitigates cerebral infarction, brain edema, and brain atrophy in rats with cerebral ischemia/reperfusion injury (CIRI), reducing both neurological deficits and histopathological damage by inhibiting neuronal apoptosis through modulation of the PKA/creb/c-Fos signaling pathway. Here, CREB1 is linked to brain infarction.